Improving next-generation cancer treatments with cryoimmunotherapy

by Olivia Dimmer,Northwestern UniversityCredit:ACS Nano(2024). DOI: 10.1021/acsnano.4c05809Northwestern Medicine scientists have developed a more effective method of delivering a cut

Updated on: October 24,2024 0

Improving next-generation cancer treatments with cryoimmunotherapy

by Olivia Dimmer,Northwestern UniversityCredit:ACS Nano(2024). DOI: 10.1021/acsnano.4c05809Northwestern Medicine scientists have developed a more effective method of delivering a cut

Updated on:October 24,2024 0

Simple test could lead to more personalized treatment of rare ovarian cancer

by University of New South WalesKaplan Meier curves of overall survival of ‘high’, ‘medium’ and ‘low’ tertiles of mRNA expression of THSB2 (left) and TAGLN (right) in MOC (n=185). Credit:Cl

Updated on: January 29,2024 20

Simple test could lead to more personalized treatment of rare ovarian cancer

by University of New South WalesKaplan Meier curves of overall survival of ‘high’, ‘medium’ and ‘low’ tertiles of mRNA expression of THSB2 (left) and TAGLN (right) in MOC (n=185). Credit:Cl

Updated on:January 29,2024 20

Rethinking the protein inhibitor approach to cancer therapy

byStony Brook UniversityTwo-step strategy for repeatable site-specific gene circuit integration.a, Network diagram of regulatory interactions and phenotypic impacts for native and ectopic

Updated on: January 22,2024 19

Rethinking the protein inhibitor approach to cancer therapy

byStony Brook UniversityTwo-step strategy for repeatable site-specific gene circuit integration.a, Network diagram of regulatory interactions and phenotypic impacts for native and ectopic

Updated on:January 22,2024 19

One lung cancer drug receives NHS England approval, while another is rejected

by Cancer Research UKCredit: CC0 Public DomainA targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer. But another precision d

Updated on: May 20,2024 4

One lung cancer drug receives NHS England approval, while another is rejected

by Cancer Research UKCredit: CC0 Public DomainA targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer. But another precision d

Updated on:May 20,2024 4

Researchers: Favorable survival, fewer side effects after reduced therapy for HPV-linked head and neck cancer

by University of North Carolina at Chapel Hill School of MedicineBhisham Chera, MD. Credit: University of North Carolina at Chapel Hill School of MedicineUniversity of North Carolina Lineberger C

Updated on: March 01,2024 11

Researchers: Favorable survival, fewer side effects after reduced therapy for HPV-linked head and neck cancer

by University of North Carolina at Chapel Hill School of MedicineBhisham Chera, MD. Credit: University of North Carolina at Chapel Hill School of MedicineUniversity of North Carolina Lineberger C

Updated on:March 01,2024 11

Expert discusses the impact and potential of cancer prevention

by Anne Trafton,Massachusetts Institute of TechnologyGreat progress has been made in reducing the cancer death toll through better prevention and screening, according to a new article by MIT Pro

Updated on: April 01,2024 20

Expert discusses the impact and potential of cancer prevention

by Anne Trafton,Massachusetts Institute of TechnologyGreat progress has been made in reducing the cancer death toll through better prevention and screening, according to a new article by MIT Pro

Updated on:April 01,2024 20

Finally, a potential new approach against KRAS-driven lung cancer

by CU Anschutz Medical CampusAlison Bauer, PhD, and colleagues identify MUC5AC as a new target in KRAS-driven lung cancer. Credit: University of Colorado Cancer CenterThe previous decade has seen

Updated on: March 21,2024 10

Finally, a potential new approach against KRAS-driven lung cancer

by CU Anschutz Medical CampusAlison Bauer, PhD, and colleagues identify MUC5AC as a new target in KRAS-driven lung cancer. Credit: University of Colorado Cancer CenterThe previous decade has seen

Updated on:March 21,2024 10

Researchers leverage cell self-destruction to treat brain tumors

by University of North Carolina Health CareAn MRI showing glioblastoma pre- and post-operation. Credit: Dominique Higgins, MD, PhDGlioblastoma is the most common type of brain tumor in adults. Th

Updated on: February 23,2024 17

Researchers leverage cell self-destruction to treat brain tumors

by University of North Carolina Health CareAn MRI showing glioblastoma pre- and post-operation. Credit: Dominique Higgins, MD, PhDGlioblastoma is the most common type of brain tumor in adults. Th

Updated on:February 23,2024 17

A half-million fewer deaths from lung cancer over 40 years

by Cancer Research UKCredit: CC0 Public DomainLung cancer death rates in men have plummeted since 1979 with nearly 500,000 fewer deaths than would have been expected if the mortality rate had sta

Updated on: March 14,2024 20

A half-million fewer deaths from lung cancer over 40 years

by Cancer Research UKCredit: CC0 Public DomainLung cancer death rates in men have plummeted since 1979 with nearly 500,000 fewer deaths than would have been expected if the mortality rate had sta

Updated on:March 14,2024 20

Attacking metastatic prostate cancer early with combination treatment approach improves outcomes in preliminary study

by Denise Heady,University of California, Los AngelesProstate cancer cells. Credit: NIH Image GalleryA team of UCLA Health Jonsson Comprehensive Cancer Center investigators has shown the combina

Updated on: March 30,2024 0

Attacking metastatic prostate cancer early with combination treatment approach improves outcomes in preliminary study

by Denise Heady,University of California, Los AngelesProstate cancer cells. Credit: NIH Image GalleryA team of UCLA Health Jonsson Comprehensive Cancer Center investigators has shown the combina

Updated on:March 30,2024 0

Study points to new drug target in fight against cancer

by Jade Boyd,Rice UniversityWhen oxidized, the protein mitoNEET (green) can close voltage-dependent anion channels, or VDACs (center), passageways that allow metabolites and signaling molecules

Updated on: May 25,2024 5

Study points to new drug target in fight against cancer

by Jade Boyd,Rice UniversityWhen oxidized, the protein mitoNEET (green) can close voltage-dependent anion channels, or VDACs (center), passageways that allow metabolites and signaling molecules

Updated on:May 25,2024 5

Phase 1 study: New medicine extends terminally-ill cancer patients' lives

by Norwegian University of Science and TechnologyMarit Otterlei (center) is a professor at the Norwegian University of Science and Technology. A new cancer drug developed by her and her colleague

Updated on: February 18,2024 12

Phase 1 study: New medicine extends terminally-ill cancer patients' lives

by Norwegian University of Science and TechnologyMarit Otterlei (center) is a professor at the Norwegian University of Science and Technology. A new cancer drug developed by her and her colleague

Updated on:February 18,2024 12